...
首页> 外文期刊>JAMA: the Journal of the American Medical Association >The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.
【24h】

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

机译:全国预防,检测,评估和治疗高血压联合委员会的第七次报告:JNC 7报告。

获取原文
获取原文并翻译 | 示例
           

摘要

"The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure" provides a new guideline for hypertension prevention and management. The following are the key messages(1) In persons older than 50 years, systolic blood pressure (BP) of more than 140 mm Hg is a much more important cardiovascular disease (CVD) risk factor than diastolic BP; (2) The risk of CVD, beginning at 115/75 mm Hg, doubles with each increment of 20/10 mm Hg; individuals who are normotensive at 55 years of age have a 90% lifetime risk for developing hypertension; (3) Individuals with a systolic BP of 120 to 139 mm Hg or a diastolic BP of 80 to 89 mm Hg should be considered as prehypertensive and require health-promoting lifestyle modifications to prevent CVD; (4) Thiazide-type diuretics should be used in drug treatment for most patients with uncomplicated hypertension, either alone or combined with drugs from other classes. Certain high-risk conditions are compelling indications for the initial use of other antihypertensive drug classes (angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, beta-blockers, calcium channel blockers); (5) Most patients with hypertension will require 2 or more antihypertensive medications to achieve goal BP (<140/90 mm Hg, or <130/80 mm Hg for patients with diabetes or chronic kidney disease); (6) If BP is more than 20/10 mm Hg above goal BP, consideration should be given to initiating therapy with 2 agents, 1 of which usually should be a thiazide-type diuretic; and (7) The most effective therapy prescribed by the most careful clinician will control hypertension only if patients are motivated. Motivation improves when patients have positive experiences with and trust in the clinician. Empathy builds trust and is a potent motivator. Finally, in presenting these guidelines, the committee recognizes that the responsible physician's judgment remains paramount.
机译:“全国预防,检测,评估和治疗高血压联合委员会的第七次报告”为高血压的预防和管理提供了新的指导方针。以下是主要信息:(1)在50岁以上的人群中,收缩压(BP)超过140毫米汞柱是比舒张压更重要的心血管疾病(CVD)危险因素; (2)从115/75毫米汞柱开始的CVD风险每增加20/10毫米汞柱就增加一倍; 55岁时血压正常的人终生患高血压的风险为90%; (3)收缩压为120至139 mm Hg或舒张压为80至89 mm Hg的个体应被视为高血压患者,并要求通过改变健康方式来预防CVD; (4)对于大多数并发高血压的患者,应单独使用噻嗪类利尿剂或与其他类别药物合用。某些高危情况是其他抗高血压药(血管紧张素转换酶抑制剂,血管紧张素受体阻滞剂,β受体阻滞剂,钙通道阻滞剂)首次使用的令人信服的迹象; (5)大多数高血压患者将需要两种或两种以上降压药物来达到目标​​BP(<140/90 mm Hg,或对于糖尿病或慢性肾脏病患者<130/80 mm Hg); (6)如果BP比目标BP高出20/10 mm Hg,则应考虑用2种药物开始治疗,其中1种通常应为噻嗪类利尿剂; (7)最谨慎的临床医生所规定的最有效的疗法只有在患者有积极性的情况下才能控制高血压。当患者对临床医生有积极的经验并信任他们时,动机会得到改善。同情心建立信任,是一种有效的激励因素。最后,委员会在提出这些指导方针时认识到,负责任医师的判断仍然至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号